These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34867816)

  • 1. Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study.
    Viggers R; Al-Mashhadi Z; Starup-Linde J; Vestergaard P
    Front Endocrinol (Lausanne); 2021; 12():771426. PubMed ID: 34867816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study.
    Viggers R; Al-Mashhadi Z; Starup-Linde J; Vestergaard P
    Front Endocrinol (Lausanne); 2021; 12():826997. PubMed ID: 35154013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
    Eiken PA; Prieto-Alhambra D; Eastell R; Abrahamsen B
    Osteoporos Int; 2017 Oct; 28(10):2921-2928. PubMed ID: 28664276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.
    Thorsteinsson AL; Vestergaard P; Eiken P
    Osteoporos Int; 2014 Jul; 25(7):1937-44. PubMed ID: 24664275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
    Pazianas M; Abrahamsen B; Eiken PA; Eastell R; Russell RG
    Osteoporos Int; 2012 Nov; 23(11):2693-701. PubMed ID: 22392160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate.
    Vestergaard P
    Calcif Tissue Int; 2011 Oct; 89(4):265-70. PubMed ID: 21710315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.
    Peng YL; Hu HY; Luo JC; Hou MC; Lin HC; Lee FY
    Osteoporos Int; 2014 May; 25(5):1617-23. PubMed ID: 24566586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study.
    Abrahamsen B; Eiken P; Prieto-Alhambra D; Eastell R
    BMJ; 2016 Jun; 353():i3365. PubMed ID: 27353596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?
    Vestergaard P
    Calcif Tissue Int; 2012 Jan; 90(1):22-9. PubMed ID: 22120197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates. A cornerstone of osteoporosis treatment.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
    [No Abstract]   [Full Text] [Related]  

  • 11. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.
    Abrahamsen B; Eiken P; Eastell R
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5258-65. PubMed ID: 20843943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
    Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density.
    Rodríguez AJ; Ernst MT; Nybo M; Prieto-Alhambra D; Ebeling PR; Hermann AP; Abrahamsen B
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32717068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke in relation to use of raloxifene and other drugs against osteoporosis.
    Vestergaard P; Schwartz K; Pinholt EM; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Apr; 22(4):1037-45. PubMed ID: 20449570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure in patients treated with bisphosphonates.
    Grove EL; Abrahamsen B; Vestergaard P
    J Intern Med; 2013 Oct; 274(4):342-50. PubMed ID: 23679231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population.
    Lin TC; Yang CY; Kao Yang YH; Lin SJ
    Osteoporos Int; 2014 May; 25(5):1503-11. PubMed ID: 24515577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.
    Vestergaard P; Schwartz K; Pinholt EM; Rejnmark L; Mosekilde L
    Osteoporos Int; 2010 Sep; 21(9):1591-7. PubMed ID: 19859641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis.
    Ringe JD; Möller G
    Rheumatol Int; 2009 Dec; 30(2):213-21. PubMed ID: 19430791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate.
    Lu PY; Hsieh CF; Tsai YW; Huang WF
    Clin Ther; 2011 Sep; 33(9):1173-9. PubMed ID: 21849210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.